The price you pay for Qutenza may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the cost of ...

Qutenza (capsaicin) is a prescription drug approved to treat nerve pain caused by shingles or diabetes. Qutenza comes as a skin patch. Specifically, Qutenza is used in adults to treat: Like most drugs ...

The cost of Qutenza can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Qutenza. As with all medications, ...

Xywav gets the nod as a low-sodium option for narcolepsy Jazz Pharmaceuticals’ Xywav (calcium, magnesium, potassium, and sodium oxybates oral solution) has been approved as a therapy for cataplexy or ...

Dosage for Qutenza (capsaicin) may depend on the condition being treated, but a dose is typically given every 3 months. Qutenza is a topical drug that’s applied to your skin by your doctor or another ...

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, which is assessing QUTENZA (capsaicin) 8% topical system to treat ...

AACHEN, Germany and MORRISTOWN, N.J., Aug. 10, 2021 /PRNewswire/ -- Grünenthal announced today that its U.S. subsidiary, Averitas Pharma Inc., enrolled the first patient in the randomised, ...

Medicare Part D may cover Qutenza if a doctor prescribes it and the pharmacy accepts Medicare. A savings program is available for those without Medicare who meet specific eligibility criteria, ...

Medicare Part D prescription drug plans and Medicare Advantage (Part C) plans with drug coverage may not cover Qutenza. However, these plans may cover other formulations of this drug. Talk with your ...

AACHEN, Germany and VICTORIA, Australia, Feb. 24, 2026 /PRNewswire/ -- Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company ...

TORONTO and AACHEN, Germany, Feb. 24, 2025 /CNW/ - Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, and Grünenthal, a global leader in pain management and related diseases, ...

Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that ...